What Skin Cycling Gets Right and What We Wanted to Take Further. Why The Layland Method was designed around skin biology as a system, not a single active

Recently, we received a note from Susan G., a woman in her sixties who is post-menopausal and has been following Level 3 of The Layland Method™. She had gone in for her quarterly Botox appointment when her practitioner commented, without prompting, on how good her skin texture looked.

We pay particular attention to observations like this when they come from someone who looks at skin all day. Injectors and aesthetic practitioners develop an unusually broad visual reference point simply through repetition: they see skin across ages, conditions and treatment histories, at close range, day after day. It remains an individual observation rather than clinical evidence, but an unsolicited comment from someone whose profession involves continually examining skin is particularly interesting.

What made Susan’s message even more interesting was something she had told us earlier about RÉAU™, our retinoid concentrate. She thought it was too gentle. Susan’s usual retinoid is A313, the French pharmacy vitamin A pommade known for its rich, occlusive texture and retinyl ester system. Compared with the sensory experience she associated with her established retinoid routine, RÉAU didn’t initially feel as though it was doing very much. She nevertheless decided to continue using it as part of the method.

That feedback stayed with us because it raises a larger question about how we learn to judge skincare. With exfoliating acids and retinoids in particular, it is easy to begin using sensation as evidence of activity. Tingling feels active. Peeling feels active. Dryness can feel like proof that turnover is occurring. A formula that produces none of those signals can, by comparison, seem somehow less serious.

But irritation and efficacy are not synonymous.

In fact, retinoid dermatitis—the dryness, scaling, redness and burning that can accompany retinoid use—is an adverse effect of treatment, not the biological endpoint we are trying to achieve. With prescription tretinoin, irritation can occur alongside a highly effective treatment, but the irritation itself is not what makes tretinoin effective. That distinction became important to our formulation philosophy.

RÉAU was intentionally designed differently. We chose retinyl linoleate, an esterified form of vitamin A that requires additional metabolic processing before reaching retinoic acid, and placed it within a broader system containing bakuchiol and CoQ10. We would not claim that this makes it equivalent to tretinoin, nor that gentleness itself is evidence of efficacy. The formulation question we were exploring was different: how much useful intervention can we achieve without making visible irritation the measure of whether a product is working?

Susan’s experience doesn’t answer that question scientifically. Her practitioner’s observation cannot be attributed to RÉAU, or to any individual product within a multi-step regimen. But the sequence was thought-provoking. Susan initially interpreted the absence of intensity as too gentle. She continued with the method. Later, someone who examines skin professionally noticed the quality of her skin without knowing anything about the regimen she had been following.

Sometimes our perception of what skincare is doing is shaped by what we can immediately feel. Skin biology is not always so theatrical.

For dry, sensitive and hormonally changing skin in particular, we became interested in the possibility that we don’t always need to overwhelm the skin in order to meaningfully work with it. Stronger sensation does not necessarily mean a better biological outcome, just as the absence of irritation does not mean the absence of activity.

That distinction sits at the heart of The Layland Method. The objective isn’t to make every intervention as aggressive as the skin can tolerate. It is to understand the biological function of each intervention, use it deliberately, and create enough space around it for the skin’s own processes of renewal and barrier maintenance to continue.

Step 1. Preparing the skin without disrupting its ecosystem (barrier and microbiome)

Cleansing was the logical place to begin because it is the first intervention in almost every regimen, and one that is easy to underestimate. By evening, the skin carries sunscreen, sebum, makeup, environmental particulate matter and residues from products applied throughout the day. These need to be removed. But the surface being cleansed also contains an intricate extracellular lipid matrix composed largely of ceramides, cholesterol and fatty acids.

These lipids are not debris. They are part of the architecture of the stratum corneum (the outermost protective layer of skin) and contribute to its ability to regulate water loss and permeability. This creates a formulation tension: cleansing needs to remove what has accumulated without unnecessarily extracting the lipids and other components that belong there.

That tension is why PASTÈSE™ was developed as a soap-free syndet (a cleansing system made with synthetic surfactants rather than traditional alkaline soap) and, more specifically, as a lipid-rich cleansing pâte rather than a conventional foaming gel. Gel cleansers can of course be formulated to be exceptionally mild; the format itself is not inherently stripping. Our choice was philosophical as much as technical. We wanted cleansing to begin in an oil- and lipid-rich environment, with enough surfactant activity to lift away the day, but without making foam, squeak or the sensation of completely degreased skin the measure of successful cleansing.

The transformation of the formula was also intentional. PASTÈSE begins as a dense pâte, but when water is worked into it, it blooms into a milk. What is happening is emulsification: the oily and lipidic phase disperses into the rinse water, turning the concentrated pâte into a fluid cleansing milk that can carry away oil-soluble residues alongside water-soluble material. We liked the experience of that transition because it makes the mechanics of cleansing almost visible—the formula moves from concentrated contact with the skin to a milky emulsion designed to rinse away.

Within that base we incorporated papaya and pineapple enzymes, sources of the proteolytic enzymes papain and bromelain (enzymes capable of breaking down proteins). Their role is not to produce an aggressive peel, but to provide gentle surface activity against protein-rich material associated with accumulated corneocytes. Again, the distinction matters: we were interested in preparing the surface for what follows, not trying to accomplish the work of a dedicated exfoliating treatment during cleansing.

Donkey milk was incorporated for a different reason, and it connects the formula to a much older history of skin care. Milk bathing has a long cultural association with Cleopatra’s beauty rituals, while donkey milk itself has a particularly interesting composition. It naturally contains lactose and other sugars, proteins and amino acids, lipids and fatty acids, minerals, and bioactive proteins such as lactoferrin and lysozyme (proteins involved in milk’s natural defense system). Rather than reducing donkey milk to a romantic historical ingredient, we were interested in the fact that it brings a chemically diverse mixture of water-soluble and lipid-associated constituents into a cleanser designed around maintaining a more conditioned skin environment.

This is also why PASTÈSE is not meant to leave the skin feeling as though nothing remains on it. The contemporary idea of a “deep clean” can sometimes confuse the sensory experience of lipid removal with cleansing efficacy. For the dry, sensitive and hormonally changing skin we formulate for, we were more interested in what the skin feels like after the rinse: clean, but not reset to zero.

The broader principle is one we return to throughout The Layland Method. An intervention should be evaluated not only by what it removes, stimulates or changes in the moment, but by the biological environment it leaves behind for whatever comes next.

Step 2. Exfoliation as assistance to process that naturally slows as we age

The same reasoning applies to exfoliation. Skin already possesses its own exfoliation mechanism, known as desquamation (the controlled release of mature surface cells from the stratum corneum). New keratinocytes are produced in the deeper layers of the epidermis and gradually differentiate as they migrate toward the surface, eventually becoming corneocytes. At the outermost layer, the structures connecting these cells are progressively broken down until the corneocytes can detach. In younger skin, this cycle of renewal and shedding tends to proceed more efficiently.

With age, however, epidermal turnover (the process by which new cells are produced, mature, move toward the surface and are eventually shed) generally becomes slower. Hormonal change adds another dimension. Estrogen influences several aspects of skin physiology, and the decline associated with menopause is accompanied by changes in epidermal function, hydration, lipid production and barrier behavior. The result is not simply that skin “stops renewing”—it doesn’t—but that some of the processes governing renewal and orderly shedding can become less efficient.

This helps explain a familiar change in aging skin. Corneocytes can remain at the surface longer and accumulate less evenly, contributing to roughness, dullness and a less uniform texture. Light also reflects differently from an irregular, dehydrated surface, which is one reason slower surface renewal can affect not only how skin feels but how luminous it appears.

Exfoliation, then, is not an attempt to introduce an artificial process. It is a way of periodically assisting one that skin already performs but may perform less efficiently with age. Alpha-hydroxy acids, or AHAs, can alter cohesion between cells within the outer layers of the stratum corneum, helping accumulated corneocytes release more readily.

But aging and hormonally changing skin presents a formulation paradox. The same skin that may benefit from help with surface renewal can also be becoming drier and more vulnerable to barrier disruption. The stratum corneum (the outermost protective layer we are trying to make smoother) is also the structure responsible for limiting water loss and helping protect the living tissue beneath it. Removing more of it, more frequently, is therefore not necessarily better.

That tension informed LISSE™. We combine 7.52% mandelic acid and 2% lactic acid with 3.4% N-acetyl glucosamine, or NAG (an amino sugar naturally related to components found within skin), more than 5% panthenol and a lipid-rich base. Mandelic acid was particularly interesting for this context because its larger molecular size relative to smaller AHAs such as glycolic acid is associated with slower penetration, making it a useful choice when we want meaningful exfoliation without designing primarily for intensity.

We also don’t regard exfoliation as something that needs to occur every evening. The objective is not to force the fastest possible turnover or to produce visible peeling as evidence that the product is working. It is to periodically assist desquamation as that natural process becomes less efficient, while recognizing that the barrier surrounding it has become increasingly important with age.

This is one of the recurring ideas behind The Layland Method: when a biological process slows, our instinct isn’t necessarily to overwhelm it. We first ask how we might work with the process that is already there.

Step 3. Emulating biology: the architecture of vitamin A metabolism

Vitamin A presented one of the clearest opportunities to apply a principle that runs throughout The Layland Method: when possible, we look to the architecture of skin biology itself for clues about how to formulate. Rather than beginning with the question of how quickly we could deliver the most biologically active form of vitamin A, we became interested in how skin naturally stores, converts and regulates vitamin A—and whether a cosmetic could work within that pathway rather than simply trying to bypass it.

Tretinoin is retinoic acid, the biologically active form of vitamin A capable of interacting directly with retinoic acid receptors (proteins inside cells that regulate gene expression in response to retinoic acid). Its evidence for photoaging is extensive. But skin’s own management of vitamin A includes a more gradual metabolic architecture. Vitamin A can be held as retinyl esters (storage forms of vitamin A) and subsequently converted through retinol and retinaldehyde before reaching retinoic acid.

Retinyl ester → retinol → retinaldehyde → retinoic acid.

Those additional steps are often discussed in skincare as disadvantages: the more conversions required, the “weaker” the retinoid is assumed to be. We became interested in looking at the same pathway differently. The intermediate forms and conversion steps are part of how biology stores and regulates access to retinoic acid. Rather than treating that distance from the active endpoint purely as something to overcome, we asked whether it could inform a different kind of cosmetic retinoid strategy.

That is the reasoning behind RÉAU™ and our choice of retinyl linoleate, an esterified form of vitamin A. It requires additional metabolic processing before reaching retinoic acid, and we would not suggest that it is equivalent to prescription tretinoin. The objective was different: to emulate aspects of vitamin A biology rather than make pharmacological directness the sole definition of sophistication.

That distinction also shaped the rest of the formula. RÉAU combines retinyl linoleate with bakuchiol and CoQ10, allowing several mechanisms relevant to visible aging and oxidative stress to coexist rather than asking increasingly intense retinoid signaling to accomplish everything.

This is where Susan G.’s early feedback became particularly interesting. Susan, who is post-menopausal and in her sixties, told us that RÉAU initially felt too gentle for her. Her established reference point was A313, the French pharmacy vitamin A pommade she had been accustomed to using. She decided to continue with RÉAU as part of The Layland Method despite wondering whether its gentleness meant it was doing enough.

That reaction captures something we think about often in active skincare: sensation can become a proxy for potency. Tingling, dryness, peeling and visible irritation are easy to interpret as evidence that something biologically meaningful is happening. But irritation is not itself the therapeutic objective of a retinoid. A treatment can be highly effective and irritating, as prescription retinoids sometimes are, but it does not follow that the irritation is what makes it effective—or that the absence of irritation means the absence of activity.

We don’t attribute Susan’s later skin-texture feedback to RÉAU; she was using a system, and an individual observation cannot establish causation. But her experience raised exactly the question that interested us when we formulated it: do we always need to overwhelm the skin in order to meaningfully influence it?

For The Layland Method, emulating biology means being interested not only in the endpoint, but in the pathway the skin uses to get there.

Step 4. Anticipating exposure: the logic of morning antioxidants

Thinking about biological rhythm also changed how we approached morning skincare. Morning and evening are not simply two opportunities to apply the same actives. During the day, skin is entering a period of relatively predictable environmental exposure. Ultraviolet radiation, visible light to some extent, air pollution and other environmental stressors can contribute to the formation of reactive oxygen species, or ROS (highly reactive molecules that can damage lipids, proteins and DNA when they accumulate beyond the skin’s antioxidant capacity). The resulting imbalance is known as oxidative stress.

This matters because oxidative stress is one of the mechanisms through which environmental exposure contributes to visible skin aging. UV-generated ROS can activate signaling pathways involved in inflammation and increase the activity of matrix metalloproteinases, or MMPs (enzymes that break down components of the skin’s extracellular matrix, including collagen). Over time, repeated exposure contributes to the changes we associate with photoaging: uneven pigmentation, loss of elasticity, changes in texture and the appearance of lines and wrinkles.

Sunscreen remains the most important daytime intervention because preventing or reducing UV exposure is more effective than attempting to manage its biological consequences afterward. But sunscreen and antioxidants perform different jobs. Even excellent photoprotection does not create an impermeable shield against every photon or every source of environmental oxidative stress. Antioxidants can therefore serve as a complementary defense system, helping neutralize reactive species that are generated despite photoprotection.

This is where vitamin C becomes particularly relevant. Vitamin C is an antioxidant (a molecule capable of donating electrons to help neutralize reactive molecules), but its biological relevance to skin extends beyond antioxidant defense. It is also an essential cofactor for enzymes involved in collagen synthesis and participates in pathways regulating melanogenesis (the biological production of melanin, the pigment responsible for skin color and many forms of hyperpigmentation). This combination of antioxidant, structural and pigment-related biology is one reason vitamin C has remained such an extensively studied ingredient in dermatology.

The formulation problem with vitamin C is that “vitamin C” does not describe a single cosmetic material. L-ascorbic acid is the biologically active form, but it is also notoriously difficult to stabilize in an aqueous cosmetic formulation and generally requires an acidic environment. Vitamin C derivatives take different chemical approaches to improving stability and formulation compatibility, with the expectation that they can ultimately contribute vitamin C activity after conversion in the skin. They are not interchangeable, however, and the evidence behind individual derivatives varies.

This informed the architecture of ROWANE™. Rather than relying on a single form, we formulated an 8.88% triple-vitamin C system using tetrahexyldecyl ascorbate, 3-O-ethyl ascorbic acid and ascorbyl glucoside. These three derivatives differ in solubility, chemical structure and behavior within a formulation. The intention was not simply to accumulate three versions of the same ingredient for a longer ingredient list, but to approach vitamin C through different formulation environments within the same emulsion.

We were also interested in what surrounds vitamin C. Oxidative stress does not involve one reactive molecule or one antioxidant pathway, and biological antioxidant systems themselves operate as networks. For that reason, ROWANE places its vitamin C system within a broader antioxidant environment that includes ferulic acid, tocotrienols and carotenoid-rich botanical oils, alongside ingredients selected for other pathways relevant to changing skin.

That broader network is important to how we think about formulation. A high percentage of a recognizable active can be useful information, but concentration alone tells us relatively little about the behavior of the finished formula. Stability, solubility, the surrounding antioxidant system, the lipid environment and the compatibility of the formula with daily use all influence whether an impressive number on a label translates into a useful product.

There is also a biological reason we prefer to place this intervention in the morning. Skin possesses its own endogenous antioxidant defenses, but these defenses are being challenged during the same period in which environmental exposure is occurring. Applying topical antioxidants before that exposure is therefore conceptually different from waiting until the evening and treating oxidative stress solely as something to correct afterward. We think of morning skincare as an opportunity to anticipate a biological burden we already know is coming.

This does not mean vitamin C only “works” in the morning, nor that applying it at night is biologically pointless. The distinction is one of purpose. Within The Layland Method, we wanted the timing of an ingredient to make sense within the larger architecture of the regimen. Morning is weighted toward photoprotection and antioxidant defense because that is when environmental exposure becomes most relevant. Evening can then accommodate interventions directed toward renewal, structural support, lipid replenishment and recovery.

This is another way regenerative thinking influenced the method. We are not trying to make every formula perform every biological function at every moment. We are asking what the skin is likely to encounter next, what support is relevant to that period, and how the rest of the regimen can be organized around it. The rhythm of the routine follows the changing demands placed on the skin, rather than the convenience of applying every active at once.

Step 5. The skin diet: recovery as part of the treatment

This systems approach became particularly important when we began researching hormonally changing skin. Declining estrogen is associated with changes across several dimensions of skin physiology, including hydration, barrier function, collagen, thickness and elasticity. The experience can therefore be paradoxical: skin may become drier and less resilient at precisely the age when we become more interested in retinoids, exfoliating acids and other interventions intended to address texture, pigmentation and structural aging.

In recent years, skin cycling helped popularize the idea that stronger treatments do not necessarily need to be used every night. The approach, widely associated with dermatologist Dr. Whitney Bowe, typically alternates exfoliation and retinoid nights with recovery nights. The terminology may be relatively new, but the underlying principle is familiar elsewhere: a stimulus and the period following that stimulus are both parts of the cycle.

We understand this intuitively when we exercise. Strength training provides a physiological stimulus, but we don’t continuously train the same muscle and assume that more stimulation will always produce a better result. Rest between sessions allows muscle tissue to repair and adapt. Skin and skeletal muscle are very different tissues, so the biology should not be conflated, but the analogy is useful: rest is not necessarily the absence of progress.

We began thinking about skincare in a similar rhythm. An exfoliating acid provides one type of intervention. A retinoid provides another. There is not necessarily an advantage to following either with another night of maximal stimulation simply because the skin can tolerate it. Particularly for dry, sensitive and hormonally changing skin, we became interested in what we provide between those more interventionist treatments.

Internally, we began thinking of this as a kind of skin diet. We don’t mean that topical skincare literally feeds skin as food feeds the body. Rather, it became a useful way of thinking about what the skin’s environment might need at different moments. Some days call for stimulation; others for lipids, humectants and structural support; and there are periods when the most appropriate approach is simply to reduce the number of variables and support a vulnerable barrier.

This is why recovery within The Layland Method isn’t represented by a single “recovery cream.” LAMELLARE™, FIRÈNE™ and BUFFÈRE™ occupy different positions within that phase because they were designed around different aspects of changing skin.

LAMELLARE is the most explicitly structural and barrier-oriented of the three. The stratum corneum (the outermost protective layer of skin) depends upon an organized extracellular lipid matrix containing ceramides, cholesterol and fatty acids. With hormonally changing skin, supporting this lipid environment becomes particularly relevant at the same time that changes in collagen, elasticity and resilience are becoming more visible. LAMELLARE therefore brings ceramides, cholesterol and phytosphingosine into the same formulation environment as GHK-Cu, Palmitoyl Tripeptide-38 and Hexapeptide-11, surrounded by panthenol, glycerin, Sodium PCA and saccharide isomerate. We stopped thinking about whether it should be a “barrier cream” or a “peptide cream” because barrier aging and structural aging are occurring in the same skin.

FIRÈNE approaches the recovery period somewhat differently. Its emphasis is on peptides and the appearance of firmness, with a 6.46% eight-peptide complex alongside liposomal caffeine, Kigelia africana, horsetail and silk amino acids. It allows us to continue addressing the visible structural changes associated with aging without making every evening another acid or retinoid evening. In other words, a recovery night doesn’t necessarily mean that the formulation is biologically uninteresting; it means we can shift the nature of the intervention away from repeated resurfacing or retinoid exposure.

BUFFÈRE occupies another position entirely. There are times when skin doesn’t need a sophisticated sequence of signals so much as a more protective environment. This may happen after professional treatments, during retinoid adaptation, after excessive exfoliation, with environmental changes, or simply during a period when the skin feels unusually dry or reactive. BUFFÈRE was designed around this more vulnerable state, with 7% ectoin, 8.10% liposomal allantoin, 5.55% jojoba phospholipids, more than 5% panthenol, Sodium PCA, saccharide isomerate, ceramides and cholesterol.

Ectoin is an extremolyte (a small protective molecule produced by certain microorganisms to help them withstand environmental stress), which made it particularly interesting to us when thinking about recovery. Rather than asking what else we could stimulate, the formulation question became: what would we use when protection, hydration and barrier support are the more relevant objectives?

This distinction matters because recovery itself is not a single state. Sometimes skin is comfortable and the recovery period can include peptides and structural support. Sometimes dryness and lipid insufficiency are more prominent. And sometimes skin is telling us quite clearly that it would prefer fewer interventions, in which case buffering and barrier support take precedence.

This is also where the regenerative-agriculture philosophy behind Layland becomes more useful than a rigid skincare schedule. Regenerative systems are managed according to conditions rather than asking the land to produce at maximum intensity continuously. There are periods of cultivation, replenishment, protection and reduced disturbance. We don’t equate soil biology with skin biology, but that philosophy influenced how we constructed the method.

The Layland Method therefore isn’t simply active night, recovery night, repeat. We think about the quality of the recovery period. LAMELLARE can emphasize barrier lipids and structural support. FIRÈNE can introduce a different peptide-focused approach to visible aging. BUFFÈRE can be used when the priority shifts more decisively toward hydration, protection and barrier comfort. And on some evenings, the appropriate skin diet may be remarkably minimal.

For hormonally changing skin, this distinction is particularly important. The objective is not to determine the maximum amount of active skincare the skin can withstand. It is to create a sustainable rhythm between stimulation, structural support, replenishment, protection and rest, adjusting that rhythm as the condition of the skin changes.

That is ultimately what we mean by recovery. It is not time lost between treatments. It is part of how the treatment is designed.Building a place for periods of vulnerability

A system designed around intervention also needs to account for periods when intervention is not the primary objective.

Skin can become temporarily more vulnerable after professional procedures, during retinoid adaptation, following excessive exfoliation, with environmental changes or simply during periods of heightened dryness and reactivity. In these circumstances, continuing to add corrective signals may not be the most appropriate response.

This is where ectoin became particularly interesting to us.

Ectoin is an extremolyte (a small molecule produced by certain microorganisms as part of their adaptation to environmental stress). Its unusual relationship with water and biological structures has made it relevant beyond conventional cosmetics, including in certain European medical-device formulations intended for irritated or compromised epithelial tissues.

Our barrier formula uses ectoin at 7%, alongside 8.10% liposomal allantoin, 5.55% jojoba phospholipids, more than 5% panthenol, Sodium PCA, saccharide isomerate, ceramides and cholesterol.

The formula itself is a cosmetic, not a medical device. What interested us about ectoin was the broader formulation concept: designing for protection and support during periods of stress rather than assuming that every treatment must increase biological stimulation.

Within The Layland Method, these periods are not interruptions to the regimen. They are part of it.

Step 6. Retention: when adding water is not enough

For persistently dry skin, hydration presents a second problem beyond getting water into the stratum corneum: keeping it there.

Water is continuously moving from the deeper layers of the skin through the epidermis and into the surrounding environment, a process known as transepidermal water loss, or TEWL. An effective barrier slows this movement, but when barrier function is impaired—or when skin is intrinsically very dry—the balance between water gained and water lost can become more difficult to maintain.

This is why we don’t think of “hydration” as a single formulation objective. Humectants (molecules that attract and bind water) can increase water content within the stratum corneum. Emollients improve softness and flexibility. Occlusive materials create a more water-resistant layer at the surface, reducing the rate at which water is lost to the environment. These functions complement one another, but they are not interchangeable.

This distinction is particularly apparent in people who describe a familiar pattern: a moisturizer makes their skin feel beautifully hydrated when first applied, yet several hours later the sensation of tightness has returned. The problem may not simply be insufficient hydration. It may also be insufficient retention.

This is the role of BASTINA™ within The Layland Method. Rather than introducing another exfoliating, antioxidant or signaling step, BASTINA is an optional lipid-rich seal applied at the end of the routine when skin benefits from greater occlusion. What is underneath it matters: humectants, water and lipids have already created a hydrated environment. The seal changes the physical conditions at the surface so that water is lost more slowly.

For very dry and hormonally changing skin, sometimes the question isn’t what additional active the skin needs. It is whether the hydration and lipids we have already applied are being retained long enough to be useful.

Step 7. Diversity without putting everything on the skin at once

The influence of regenerative agriculture also shaped the way we thought about diversity.

Diversity is an important principle in many regenerative agricultural systems because a resilient system is rarely understood through a single input. We don’t extrapolate from this that botanical diversity is inherently superior in skincare; soil and skin are fundamentally different biological systems. But it prompted a formulation question that became important to The Layland Method: if different ingredients address different aspects of skin biology, do they all need to be applied at the same time?

Our answer was no.

LESOINE™ emerged from this part of the thinking. It is a nutrient-rich gelée built around a deliberately broad collection of beta glucans and other polysaccharide-rich materials, ferments, botanical extracts, phospholipids and minerals. Rather than making it another obligatory layer in an already complex routine, we use it as a way of introducing a different formulation environment into the rotation.

Some of these materials have very different histories and chemical compositions. Tepezcohuite has a long history of traditional skin use in Mexico. Dragon’s blood is a resin with a history of ethnobotanical use in the Amazon. Reishi contributes beta glucans and other fungal polysaccharides, while guava leaf ferment, onion extract, Centella asiatica and mineral components introduce still other chemical families. The interest for us isn’t that “natural” necessarily means better. It is that botanical, fungal, mineral and fermentation-derived materials can introduce a very different spectrum of constituents from the peptides, retinoids and exfoliating acids used elsewhere in the method.

Importantly, this is not “skin confusion.” There is little reason to assume that skin needs to be surprised by its skincare or that an effective ingredient stops working simply because it becomes familiar.

The rationale is more practical. Different days can have different biological objectives. One evening may emphasize desquamation. Another vitamin A. Another peptides, lipids and hydration. Another may introduce a broader botanical-, polysaccharide- and ferment-rich environment. Rotation allows us to vary the nature of the intervention without continually increasing the number of simultaneous interventions.

Returning to the whole

This is what we mean when we describe The Layland Method as holistic. We don’t use the word as an alternative to scientific thinking, but in its literal sense: considering the whole system and the relationships among its parts.

Barrier condition influences active tolerance. Desquamation influences texture. Water content affects the physical and optical properties of the stratum corneum. Oxidative stress contributes to photoaging. Hormonal change can affect multiple compartments of skin simultaneously. Occlusion changes the water-loss environment created by everything applied underneath it.

The Layland Method therefore isn’t designed around performing every possible intervention every day. It is organized around understanding what each intervention is intended to accomplish, when it is most useful, and what the skin may need before and after it.

This brings us back to Susan G.

Her practitioner’s observation does not establish the efficacy of The Layland Method, and we would never present an individual experience as clinical evidence. What interested us was the nature of the observation. Her practitioner didn’t know which vitamin A derivative Susan had been applying, the percentage of vitamin C she used in the morning, which peptides or lipids were part of her evening routine, or whether the previous evening had been an active night or a recovery night. She wasn’t evaluating any of those variables independently.

She simply noticed that Susan’s skin texture looked good.

Texture itself is an aggregate outcome. Hydration, surface-cell organization, desquamation, barrier condition, inflammation, pigmentation and the underlying structural characteristics of skin can all influence what we ultimately perceive as smoothness, luminosity and evenness. No single observation can tell us which of those processes changed, or why.

But that is precisely why the comment stayed with us. The Layland Method was never designed around the premise that one ingredient should explain the condition of the skin. It was designed around the more complex reality that visible skin quality emerges from multiple biological processes occurring simultaneously—and that a thoughtful regimen should account not only for what we ask the skin to do, but also for the environment in which we are asking it to do it.

— Steinder Weisen
Maison de Formulation